Organization
Chengdu, China
8 abstracts
Abstract
Characterization of T-cell receptor repertoire and correlation with tumor mutational landscape in lung cancer.Org: HaploX Biotechnology, Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Chengdu, China,
Abstract
68Ga-FAPI-04 positron emission tomography/computed tomography (PET/CT) for detecting occult peritoneal metastasis in locally advanced gastric cancer: A single-center prospective cohort study.Org: Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, West China Hospital, Sichuan University, Chengdu, China, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
A phase IIA clinical trial to evaluate a reversible Bruton’s tyrosine kinase inhibitor (BTKi) HBW-3220 capsules in patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL).Org: Chengdu Hyperway Pharmaceuticals, Chengdu, China,
Abstract
A pilot trial of personalized neoantigen pulsed autologous dendritic cell vaccine as adjuvant treatment in hepatocellular carcinoma.Org: Cancer Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China, West China Hospital, Sichuan University, Chengdu, China,
Abstract
Ozone-loaded Pt(IV) prodrug self-assembled micelles with high bioavailability, low toxicity as a novel irradiation-controlled release treatment and the immune microenvironment editor for triple-negative breast cancer.Org: West China Hospital, Sichuan University, Chengdu, China, Breast Disease Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China,
Abstract
Association of CAR-T cell secreting CD47 blocking protein with an enhanced antitumor activity in small cell lung cancer.Org: Clinical Trial Center and Department of Epidemiology - IRCCS Ospedale Policlinico San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, West China Hospital, Chengdu, China,
Abstract
Auranofin and the efficacy of anti-PD1 immunotherapy.Org: Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China,
Abstract
Abnormal bone and cartilage metabolism could be antagonised by pulsed electromagnetic fields (PEMFS) and tnf-Α and il-6 gene knockouts in a similar mechanismOrg: Rehabilitation Medicine and MOVE research institute, VU University Medical Center, West China Hospital, Sichuan University School of Aeronautics and Astronautics, Sichuan University Institute for Disaster Management and Reconstruction, Sichuan University-The Hong Kong Polytechnic University,